Cathy Cojean

Title: **Cathy Cojean: Innovator in High-Throughput Screening Technologies**

Introduction

Cathy Cojean is an accomplished inventor based in Massy, France, recognized for her significant contributions to the field of biotechnology. With a focus on developing innovative solutions for high-throughput screening assays, Cojean has made noteworthy advancements in the understanding and application of nematode acetylcholine receptors.

Latest Patents

Cojean holds a patent titled “Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays.” This invention describes the development of mammalian cell lines that stably express functional nematode acetylcholine receptor subunits. The innovative aspect of this patent lies in the stable co-expression of the chaperone protein, RIC3, which facilitates the expression of functional ion channels. These engineered cell lines are invaluable for high-throughput screening of compounds aimed at identifying new parasiticidal and nematocidal active ingredients.

Career Highlights

Throughout her career, Cathy Cojean has worked with prestigious companies such as Boehringer Ingelheim Animal Health, Inc. and Sanofi. Her endeavors in these organizations have allowed her to enhance her expertise and contribute significantly to the biopharmaceutical landscape.

Collaborations

Cojean's work has been supported through collaborations with notable colleagues, including Lance Hammerland and Brenda Bondesen. These partnerships have played a crucial role in advancing her research and innovations in the field.

Conclusion

Cathy Cojean’s innovative contributions to high-throughput screening technologies highlight her position as a leading inventor in biotechnology. Her patent serves as a testament to her commitment to advancing science and developing novel solutions for parasitic infections, paving the way for future developments in the industry.